Skip to main content
PRVA
NASDAQ Industrial Applications And Services

Privia 10-Q: Q3 Revenue $657.0M, Net Income $13.5M; OIG Inquiry and Negative YTD Operating Cash Flow Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$23.19
Mkt Cap
$2.861B
52W Low
$18.915
52W High
$28.82
52W Position info
23% above low
Off High info
20% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

PRVA sits 23% above its 52-week low of $18.915 on elevated volume (2.3× avg).

Summary

Privia's Q3 10-Q confirms $657.0M revenue (+13.2%) and $13.5M net income, but also reveals a $19.4M nine-month operating cash outflow and a previously undisclosed OIG inquiry into a former practice.


Key Events · Earnings and Guidance · PRVA

  • Q3 Revenue Up 13.2% to $657.0M

    Revenue rose to $656.96M from $580.4M a year earlier, with FFS-patient care up $80.5M to $433.1M. Net income attributable to Privia nearly doubled to $13.5M from $6.9M, and diluted EPS was $0.10 versus $0.05.

  • Operating Cash Flow Turns Negative

    Nine-month operating activities used $19.4M versus $35.9M provided in 2025, driven by a $221.8M receivables build (accounts receivable $623.6M vs $400.9M at year-end). Cash fell to $446.3M from $479.7M; the $250M revolver is undrawn.

  • OIG Inquiry Into Former Practice

    On March 24, 2026 the company received an HHS-OIG request for information about a former Mid-Atlantic OB/GYN Affiliated Practice's device procurement and implantation compliance, coordinated with the DOJ and Virginia's Attorney General. Management does not currently expect a material adverse effect but cannot assure the scope or outcome.

  • Cano Health ACO Deal Closed November 1

    Subsequent to quarter-end, Privia acquired an ACO business from Cano Health, LLC for approximately $36.0M in cash at closing; purchase accounting is incomplete and will be reported in the 2026 10-K.


Analysis · PRVA · Industrial Applications And Services

The headline numbers match this morning's 8-K, but the full 10-Q carries two things the press release did not. First, cash generation has reversed: operating activities used $19.4M over the first nine months versus $35.9M provided a year earlier, as accounts receivable ballooned to $623.6M from $400.9M. Cash on hand is still a healthy $446.3M and the $250M revolver is undrawn, so this is a working-capital swing rather than a liquidity problem — but it is the metric to track next quarter. Second, the company disclosed a March 2026 OIG request for information about a former Mid-Atlantic OB/GYN practice's device implantation practices, being handled alongside the DOJ and Virginia's Attorney General. Management says it does not expect a material impact, yet the scope and outcome are unknown, which adds regulatory overhang to a stock that just beat on revenue and nearly doubled net income.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PRVA was trading at $23.19 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.9B. The 52-week trading range was $18.92 to $28.82. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PRVA - Latest Insights

PRVA
Nov 18, 2026, 8:38 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $25.26
Real-time Price: $25.05 info
Change: -$0.210 (-0.83%) info
Market Cap: $3.201B info
PRVA
Nov 18, 2026, 8:30 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $25.26
Real-time Price: $25.05 info
Change: -$0.210 (-0.83%) info
Market Cap: $3.201B info
PRVA
Nov 05, 2026, 6:10 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $25.05 info
Change: +$3.05 (+14%) info
Market Cap: $3.201B info
PRVA
Nov 05, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $22.00
Real-time Price: $25.05 info
Change: +$3.05 (+14%) info
Market Cap: $3.201B info
PRVA
Nov 02, 2026, 8:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $21.48
Real-time Price: $25.05 info
Change: +$3.57 (+17%) info
Market Cap: $3.201B info